CAPR logo

Capricor Therapeutics (CAPR) Working Capital

Annual Working Capital

$19.59 M
+$283.50 K+1.47%

31 December 2023

CAPR Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$65.35 M
+$57.03 M+685.96%

30 September 2024

CAPR Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CAPR Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+233.7%
3 y3 years-39.4%+102.3%
5 y5 years+103.0%+577.4%

CAPR Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-39.4%+1.5%at high+2022.5%
5 y5 years-39.4%+103.0%at high+2022.5%
alltimeall time-39.4%>+9999.0%at high+2022.5%

Capricor Therapeutics Working Capital History

DateAnnualQuarterly
Sept 2024
-
$65.35 M(+686.0%)
June 2024
-
$8.31 M(-44.7%)
Mar 2024
-
$15.03 M(-23.3%)
Dec 2023
$19.59 M(+1.5%)
$19.59 M(-676.2%)
Sept 2023
-
-$3.40 M(-190.1%)
June 2023
-
$3.77 M(-60.1%)
Mar 2023
-
$9.46 M(-51.0%)
Dec 2022
$19.30 M(-40.2%)
$19.30 M(-20.6%)
Sept 2022
-
$24.31 M(-26.5%)
June 2022
-
$33.08 M(-27.0%)
Mar 2022
-
$45.31 M(+40.3%)
Dec 2021
$32.30 M(+5.2%)
$32.30 M(-15.7%)
Sept 2021
-
$38.31 M(+7.7%)
June 2021
-
$35.56 M(-8.5%)
Mar 2021
-
$38.86 M(+26.6%)
Dec 2020
$30.71 M(+218.3%)
$30.71 M(-7.5%)
Sept 2020
-
$33.21 M(-4.1%)
June 2020
-
$34.63 M(+178.3%)
Mar 2020
-
$12.45 M(+29.0%)
Dec 2019
$9.65 M(+33.7%)
$9.65 M(+52.4%)
Sept 2019
-
$6.33 M(+24.7%)
June 2019
-
$5.08 M(-20.7%)
Mar 2019
-
$6.40 M(-11.3%)
Dec 2018
$7.22 M(-48.6%)
$7.22 M(-24.2%)
Sept 2018
-
$9.52 M(-22.1%)
June 2018
-
$12.22 M(-7.0%)
Mar 2018
-
$13.14 M(-6.5%)
Dec 2017
$14.04 M(+6.3%)
$14.04 M(-1064.7%)
Sept 2017
-
-$1.46 M(-51.5%)
June 2017
-
-$3.00 M(-129.6%)
Mar 2017
-
$10.17 M(-23.1%)
Dec 2016
$13.21 M(+77.1%)
$13.21 M(-16.0%)
Sept 2016
-
$15.73 M(+180.8%)
June 2016
-
$5.60 M(-25.8%)
Mar 2016
-
$7.55 M(+1.2%)
Dec 2015
$7.46 M(+40.6%)
$7.46 M(-33.3%)
Sept 2015
-
$11.18 M(-24.4%)
June 2015
-
$14.78 M(-17.3%)
Mar 2015
-
$17.88 M(+236.8%)
Dec 2014
$5.31 M(+226.1%)
$5.31 M(-33.7%)
Sept 2014
-
$8.00 M(-19.3%)
June 2014
-
$9.92 M(+28.3%)
Mar 2014
-
$7.73 M(+374.9%)
Dec 2013
$1.63 M(-65.1%)
$1.63 M(-251.7%)
Sept 2013
-
-$1.07 M(+47.7%)
June 2013
-
-$726.30 K(+196.7%)
Mar 2013
-
-$244.80 K(-105.2%)
DateAnnualQuarterly
Dec 2012
$4.66 M(+506.5%)
$4.66 M(+2984.7%)
Sept 2012
-
$151.20 K(-77.6%)
June 2012
-
$674.80 K(+295.1%)
Mar 2012
-
$170.80 K(-77.8%)
Dec 2011
$769.00 K(-69.6%)
$769.00 K(-66.7%)
Sept 2011
-
$2.31 M(-27.9%)
June 2011
-
$3.20 M(+99.2%)
Mar 2011
-
$1.61 M(-36.4%)
Dec 2010
$2.53 M(-9.6%)
$2.53 M(-21.9%)
Sept 2010
-
$3.24 M(-30.4%)
June 2010
-
$4.65 M(+230.5%)
Mar 2010
-
$1.41 M(-49.7%)
Dec 2009
$2.80 M(-40.7%)
$2.80 M(-24.7%)
Sept 2009
-
$3.71 M(+144.9%)
June 2009
-
$1.52 M(-52.2%)
Mar 2009
-
$3.17 M(-32.8%)
Dec 2008
$4.71 M(-68.3%)
$4.71 M(-33.5%)
Sept 2008
-
$7.09 M(-27.4%)
June 2008
-
$9.76 M(-23.3%)
Mar 2008
-
$12.73 M(-14.4%)
Dec 2007
$14.87 M(<-9900.0%)
$14.87 M(-12.8%)
Sept 2007
-
$17.05 M(<-9900.0%)
June 2007
-
-$168.10 K(+15.9%)
Mar 2007
-
-$145.10 K(+7.6%)
Dec 2006
-$134.80 K(+73.7%)
-$134.80 K(+8.1%)
Sept 2006
-
-$124.70 K(+39.0%)
June 2006
-
-$89.70 K(+8.3%)
Mar 2006
-
-$82.80 K(+6.7%)
Dec 2005
-$77.60 K(+32.0%)
-$77.60 K(+10.1%)
Sept 2005
-
-$70.50 K(+5.1%)
June 2005
-
-$67.10 K(+4.5%)
Mar 2005
-
-$64.20 K(+9.2%)
Dec 2004
-$58.80 K(+44.5%)
-$58.80 K(+18.8%)
Sept 2004
-
-$49.50 K(+7.6%)
June 2004
-
-$46.00 K(+6.5%)
Mar 2004
-
-$43.20 K(+6.1%)
Dec 2003
-$40.70 K(+66.1%)
-$40.70 K(+15.3%)
Sept 2003
-
-$35.30 K(+0.3%)
June 2003
-
-$35.20 K(+24.8%)
Mar 2003
-
-$28.20 K(+15.1%)
Dec 2002
-$24.50 K(+172.2%)
-$24.50 K(+17.8%)
Sept 2002
-
-$20.80 K(+70.5%)
June 2002
-
-$12.20 K(+351.9%)
Mar 2002
-
-$2700.00(-70.0%)
Dec 2001
-$9000.00(-167.7%)
-$9000.00
Dec 2000
$13.30 K(-1577.8%)
-
Dec 1999
-$900.00
-

FAQ

  • What is Capricor Therapeutics annual working capital?
  • What is the all time high annual working capital for Capricor Therapeutics?
  • What is Capricor Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Capricor Therapeutics?
  • What is Capricor Therapeutics quarterly working capital year-on-year change?

What is Capricor Therapeutics annual working capital?

The current annual working capital of CAPR is $19.59 M

What is the all time high annual working capital for Capricor Therapeutics?

Capricor Therapeutics all-time high annual working capital is $32.30 M

What is Capricor Therapeutics quarterly working capital?

The current quarterly working capital of CAPR is $65.35 M

What is the all time high quarterly working capital for Capricor Therapeutics?

Capricor Therapeutics all-time high quarterly working capital is $65.35 M

What is Capricor Therapeutics quarterly working capital year-on-year change?

Over the past year, CAPR quarterly working capital has changed by +$45.76 M (+233.65%)